Mostrar el registro sencillo del ítem

Viral Related Tools against SARS-CoV-2

dc.contributor.authorFernández García, Laura
dc.contributor.authorPacios Santamaria, Olga
dc.contributor.authorGonzález Bardanca, Sonia
dc.contributor.authorBlasco Otero, Lucía
dc.contributor.authorBleriot Rial, Ines Maria
dc.contributor.authorAmbroa Abalo, Antón
dc.contributor.authorLópez Díaz, María José 
dc.contributor.authorBou Arévalo, Germán 
dc.contributor.authorTomás Carmona, María del Mar 
dc.date.accessioned2022-03-04T07:45:59Z
dc.date.available2022-03-04T07:45:59Z
dc.date.issued2020
dc.identifier.issn1999-4915
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/33081350es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16151
dc.description.abstractAt the end of 2019, a new disease appeared and spread all over the world, the COVID-19, produced by the coronavirus SARS-CoV-2. As a consequence of this worldwide health crisis, the scientific community began to redirect their knowledge and resources to fight against it. Here we summarize the recent research on viruses employed as therapy and diagnostic of COVID-19: (i) viral-vector vaccines both in clinical trials and pre-clinical phases; (ii) the use of bacteriophages to find antibodies specific to this virus and some studies of how to use the bacteriophages themselves as a treatment against viral diseases; and finally, (iii) the use of CRISPR-Cas technology both to obtain a fast precise diagnose of the patient and also the possible use of this technology as a cure.en
dc.language.isoenes
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshViral Vaccines*
dc.subject.meshBacteriophages*
dc.subject.meshPandemics*
dc.subject.meshCRISPR-Cas Systems*
dc.subject.meshHumans*
dc.subject.meshAntibodies*
dc.subject.meshCoronavirus Infections*
dc.subject.meshPneumonia*
dc.subject.meshAntiviral Agents*
dc.titleViral Related Tools against SARS-CoV-2en
dc.typeJournal Articlees
dc.authorsophosFernandez-Garcia, Laura;Pacios, Olga;González-Bardanca, Mónica;Blasco, Lucia;Bleriot, Inés;Ambroa, Antón;López, María;Bou, German;Tomás, Maria
dc.identifier.doi10.3390/v12101172
dc.identifier.pmid33081350
dc.identifier.sophos35556
dc.issue.number10es
dc.journal.titleViruses-Baseles
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario de A Coruña::Microbioloxía
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Biomédica da Coruña (INIBIC)
dc.relation.publisherversionhttps://mdpi-res.com/d://attachment/viruses/viruses-12-01172/article://deploy/viruses-12-01172-v2.pdfes
dc.rights.accessRightsopenAccess
dc.subject.decsneumonía*
dc.subject.decsbacteriófagos*
dc.subject.decsantivíricos*
dc.subject.decspandemias*
dc.subject.decshumanos*
dc.subject.decssistemas CRISPR-Cas*
dc.subject.decsanticuerpos*
dc.subject.decsvacunas víricas*
dc.subject.decsinfecciones por Coronavirus*
dc.subject.keywordCHUACes
dc.subject.keywordINIBICes
dc.typefidesArtículo de Revisiónes
dc.typesophosArtículo de Revisiónes
dc.volume.number12es


Ficheros en el ítem

Descargar/
Nombre:
35556-31.pdf
Tamaño:
861.8Kb
Formato:
PDF
Descripción:
Viruses. 2020 Oct 16;12(10):1172. doi: 10.3390/v12101172

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional